Original Research

Human epidermal growth factor receptor 2-positive breast cancer: which cytotoxic agent best complements trastuzumab's efficacy in vitro?

Hurrell T, Outhoff K

OncoTargets and Therapy 2013, 6:693-701

Published Date: 17 June 2013